Endothelial-to-Mesenchymal Transition in Cancer - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Frontiers in Cell and Developmental Biology Année : 2020

Endothelial-to-Mesenchymal Transition in Cancer

Résumé

Cancer is one of the most important causes of morbidity and mortality worldwide. Tumor cells grow in a complex microenvironment constituted of immune, stromal, and vascular cells that supports growth, angiogenesis, and metastasis. Endothelial cells (ECs) are major components of the vascular microenvironment. These cells have been described for their plasticity and potential to transdifferentiate into mesenchymal cells through a process known as endothelial-to-mesenchymal transition (EndMT). This complex process is controlled by various factors, by which ECs convert into a phenotype characterized by mesenchymal protein expression and motile, contractile morphology. Initially described in normal heart development, EndMT is now identified in several pathologies, and especially in cancer. In this review, we highlight the process of EndMT in the context of cancer and we discuss it as an important adaptive process of the tumor microenvironment that favors tumor growth and dissemination but also resistance to treatment. Thus, we underline targeting of EndMT as a potential therapeutic strategy.
Fichier principal
Vignette du fichier
clere-2020.pdf (523.91 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02917778 , version 1 (20-10-2020)

Licence

Paternité

Identifiants

Citer

Nicolas Clere, Sarah Renault, Isabelle Corre. Endothelial-to-Mesenchymal Transition in Cancer. Frontiers in Cell and Developmental Biology, 2020, 8 (747), pp.1-8. ⟨10.3389/fcell.2020.00747⟩. ⟨hal-02917778⟩
97 Consultations
159 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More